ARCHIVES

Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

Study Finds Nearly Two-Thirds Of Children Return to Hospital Following Stem Cell Transplant

April 26, 2013

Breast Cancer Vs. Other Cancers In Budget Showdown

July 3, 1992

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

NCAB: An Extraordinary Opportunity For Budgetary Coordination.

February 25, 2000

Historical Vs. Current Controls: Comparability, Ethical Issues Argued By Moertel, Freireich

April 20, 1979

In Brief: NCI Encourages New Grants In For Cancer Sites In Forthcoming PA, Broder Informs Grantees

January 3, 1992